logo
Plus   Neg
Share
Email

Moody's Boosts FY19 Adj. EPS Outlook - Quick Facts

While reporting financial results for the second quarter, Moody's Corp. (MCO) on Wednesday raised its adjusted earnings guidance for the full-year 2019 in light of the first half performance exceeding expectations.

For fiscal 2019, the company now expects earnings in a range of $7.15 to $7.35 per share and adjusted earnings in the range of $7.95 to $8.15 per share on projected revenue growth in the mid-single-digit percent range.

Previously, the company projected earnings in the range of $7.30 to $7.55 per share and adjusted earnings in the range of $7.85 to $8.10 per share on revenue growth in the mid-single-digit percent range.

On average, 16 analysts polled by Thomson Reuters expect earnings of $8.00 per share on revenue growth of 5.5 percent to $4.69 billion for the year. Analysts' estimates typically exclude special items.

Earlier in the month, the company's Board of Directors declared a regular quarterly dividend of $0.50 per share of Moody's common stock, payable on September 10, 2019 to stockholders of record at the close of business on August 20, 2019.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Apple Inc. is taking necessary precautions including Covid-19 testing for those employees returning to work at its headquarters in Silicon Valley, Bloomberg reported citing people familiar with the process. The company, which opened its main Apple Park office in May bringing back some hardware and software engineers, plans the gradual reopening of the building keeping the coronavirus safeguards. A U.S. appeals court has blocked the sales of Bayer AG's dicamba-based Xtendimax in the United States. The three-judge panel in the U.S. Court of Appeals for the Ninth Circuit ruled that the US Environmental Protection Agency (EPA) overstated the protections and substantially understated or ignored the risks related to the use of dicamba-based herbicides. Tesla Chief Executive Officer Elon Musk has called for a breakup of Amazon after the online retail giant refused to publish an upcoming book about COVID-19. Writer Alex Berenson said on Twitter that Amazon refused to publish his booklet about the coronavirus as it did not comply with the company's guidelines. Berenson is a former New York Times reporter.
Follow RTT